RegMed Daily, Closing Bell, 4/25/12, stocks gain, NASDAQ rolls up 2.3% as sector slips and expectation continues as a disaster
End of Day, Cause and Effect
EOD Commentary: RegMed stocks rose early and fell later on Wednesday after interest wained … and the Fed kept interest rates unchanged in addition to boosting its growth outlook. In addition, the Fed’s Bernanke reiterated that the central bank remains prepared to take action to help the economy, if needed.
Closing Bell: The NASDAQ closed UP +68.03 (+2.3%) to 3,029.63. The Dow closed UP +89.39 <+0.69%) to 13,090.95.
Who’s up … at the close:
- Athersys (ATHX) +$0.06 <+4.44%> to $1.41;
- Cryo-Cell (OTC BB: CCEL) +$0.23 <+10.60%> to $2.40;
- Cytori (CYTX) +$0.11 <+4.7%> to $2.45;
- Dendreon (DNDN) +$0.18 <+1,59%> to $11.49;
- Geron (GERN) +$0.04 <+2.41%> to $1.70;
- Neuralstem (Amex: CUR) +$02 <+1.96> to $1.04;
- ReNeuron (RENE.L) +$0.06 <+1.52%> to $4.02;
Related Posts
Categories: RegMed Daily Closing Bell
